Growth leadership Executive appointment of a new CEO Brijesh Patel in August 2024 and a newly appointed Senior Vice President for Strategic Growth & Advisory Khalid Raja in April 2026 indicate a focus on strategic expansion, partnership development, and scaling capabilities—an opportunity to position story around growth enablement, advisory services, and global market penetration.

Regulatory excellence ECI specializes in quality, regulatory, and compliance across life sciences, with end-to-end support from development to post-market remediation. This creates cross-sell potential into clients seeking enhanced quality systems, risk management, and ongoing compliance optimization using tech-enabled solutions.

Global delivery Global footprint with headquarters in the US and operations in Costa Rica, Ireland, and India suggests readiness to scale engagements, offer nearshoring/flexible delivery models, and provide multi-regional regulatory and quality system support for global manufacturers.

Tech enabled A tech stack including SOLIDWORKS, OneTrust, Microsoft 365, HubSpot/Pardot, and Webflow indicates the ability to integrate engineering, compliance, data privacy, and marketing automation—presenting opportunities to upsell integrated software-enabled compliance and quality workflows.

Financial target Reported revenue in the range of $100M–$250M positions ECI as a mid-market player with appetite for expanding service lines, strategic partnerships, and scalable programs; sales plays could focus on expanding into higher-value diagnostics, validation, and remediation projects with longer contract terms.